pseudomonas aeruginosa key player pathology morbidity cystic fibrosis chronic obstructive pulmonary disease results common severe mutations genetic disorder typically includes chronic infection p aeruginosa rugged antibiotic physical therapy regimens rarely eradicated known increased oligosaccharide sulfation characteristic cystic fibrosis tracheobronchial mucins plays role survival p aeruginosa airway study sulfated monosaccharides synthesized tested effects growth clinical isolates laboratory strains organism supplied sole carbon source vitro carbohydrate sulfation observed reduce prohibit growth p aeruginosa carbohydrates normally utilized nonsulfated form various sulfated sugars employed sole carbon source gave characteristic consistent growth profiles maximum growth values strains tested p aeruginosa isolates patients cystic fibrosis express mucoid phenotype thought contribute ability survive harsh conditions carbohydrate sulfation effects growth did differ significantly mucoid nonmucoid strains results suggest additional sulfation tracheobronchial mucin documented cystic fibrosis fact contribute mucins resistance utilization p aeruginosa potentially pathogens providing additional level host protection limiting available nutrient pool bacterial growth